In crucial win, bluebird nabs a second FDA committee endorsement


In a key win for the embattled biotech, bluebird bio Inc. has scored two endorsements in as many days from an advisory committee to the U.S. Food and Drug Administration.

Previous San Antonio-headquartered Victory Capital reports $6B increase in assets since last year
Next Emerging Leaders: To stay on top of mental health in the workplace, prioritize personal engagement